Bismuth quadruple therapy
Bismuth quadruple therapy is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication
Clinical Trials (6)
Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication
Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6